Fresenius Medical Care AG (FMCQF) Cash from Financing Activities (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has 17 years of Cash from Financing Activities data on file, last reported at -$242.6 million in Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 76.48% year-over-year to -$242.6 million; the TTM figure through Dec 2025 stood at -$1.6 billion (up 41.33% YoY), while the FY2025 annual figure was -$1.6 billion, up 40.51% from the prior year.
• Cash from Financing Activities advanced to -$242.6 million in Q4 2025, from -$1.3 billion in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $89.7 million in Q2 2025 and bottomed at -$1.3 billion in Q3 2025.
• A 5-year average of -$466.1 million and a median of -$410.7 million in 2021 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities plunged 14656.63% — and 2025, when it jumped 109.94%.
• Year by year, Cash from Financing Activities stood at -$409.0 million in 2021, then surged by 70.09% to -$122.3 million in 2022, then sank by 555.76% to -$802.3 million in 2023, then decreased by 28.56% to -$1.0 billion in 2024, then soared by 76.48% to -$242.6 million in 2025.
• The last three Cash from Financing Activities figures came in at -$242.6 million (Q4 2025), -$1.3 billion (Q3 2025), and $89.7 million (Q2 2025), per Business Quant data.

Peer Comparison